| Number at risk | Diabetes cases | Unadjusted | Model 1 | Model 2 | |||
---|---|---|---|---|---|---|---|---|
HR (95Â % CI) | P for trend | HR (95Â % CI) | P for trend | HR (95Â % CI) | P for trend | |||
Normal BP | ||||||||
 Men | ||||||||
  Quartile 1 | 446 | 43 | 1 (reference) | <0.001 | 1 (reference) | <0.001 | 1 (reference) | <0.001 |
  Quartile 2 | 443 | 48 | 1.06 (0.70–1.60) | 1.07 (0.71–1.61) | 1.09 (0.72–1.64) | |||
  Quartile 3 | 440 | 57 | 1.31 (0.88–1.94) | 1.34 (0.90–1.99) | 1.27 (0.85–1.90) | |||
  Quartile 4 | 443 | 79 | 1.90 (1.31–2.76)* | 1.94 (1.34–2.82)* | 1.50 (1.02–2.21)* | |||
 Women | ||||||||
  Quartile 1 | 541 | 36 | 1 (reference) | <0.001 | 1 (reference) | <0.001 | 1 (reference) | <0.001 |
  Quartile 2 | 542 | 41 | 1.13 (0.72–1.76) | 1.14 (0.73–1.79) | 1.16 (0.74–1.82) | |||
  Quartile 3 | 543 | 56 | 1.53 (1.01–2.34)* | 1.60 (1.05–2.44)* | 1.60 (1.05–2.45)* | |||
  Quartile 4 | 538 | 79 | 2.15 (1.45–3.18)** | 2.19 (1.48–3.25)** | 2.02 (1.35–3.02)** | |||
Prehypertension | ||||||||
 Men | ||||||||
  Quartile 1 | 241 | 35 | 1 (reference) | <0.001 | 1 (reference) | <0.001 | 1 (reference) | <0.001 |
  Quartile 2 | 234 | 34 | 0.91 (0.57–1.46) | 0.89 (0.56–1.43) | 0.85 (0.53–1.37) | |||
  Quartile 3 | 239 | 39 | 1.14 (0.72–1.80) | 1.14 (0.72–1.80) | 1.10 (0.69–1.74) | |||
  Quartile 4 | 235 | 60 | 1.70 (1.12–2.58)* | 1.78 (1.17–2.71)* | 1.42 (0.92–2.18) | |||
 Women | ||||||||
  Quartile 1 | 205 | 24 | 1 (reference) | <0.001 | 1 (reference) | <0.001 | 1 (reference) | <0.001 |
  Quartile 2 | 204 | 28 | 1.16 (0.67–2.00) | 1.15 (0.67–1.99) | 1.18 (0.68–2.05) | |||
  Quartile 3 | 207 | 33 | 1.26 (0.75–2.13) | 1.25 (0.74–2.12) | 1.38 (0.81–2.34) | |||
  Quartile 4 | 201 | 41 | 1.67 (1.01–2.77)* | 1.70 (1.02–2.82)* | 1.63 (0.97–2.73) |